JANUS HENDERSON GROUP PLC

Holdings History for Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)

Symbol: TARA on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 5,141,616 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in Protara Therapeutics, Inc. Common Stock, par value $0.001 per share (TARA)

17 Feb 2026 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,141,616 shares of Protara Therapeutics, Inc. Common Stock, par value $0.001 per share (TARA). This represents 10% ownership of the company. In their previous filing dated 14 Nov 2025, JANUS HENDERSON GROUP PLC had reported owning 4,231,331 shares, indicating an increase of +22%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
JANUS HENDERSON GROUP PLC	10%	-9.1%	$29,564,292	5,141,616	+910,285	+22%	$5.75	13G/A	31 Dec 2025	17 Feb 2026, 16:33
JANUS HENDERSON GROUP PLC	11%	+3.6%	$18,406,290	4,231,331	+128,711	+3.1%	$4.35	13G/A	30 Sep 2025	14 Nov 2025, 11:58
JANUS HENDERSON GROUP PLC	11%	+0.91%	$12,430,939	4,102,620	+240,069	+6.2%	$3.03	13G/A	30 Jun 2025	14 Aug 2025, 11:15
JANUS HENDERSON GROUP PLC	10%	+2%	$16,686,220	3,862,551	+74,375	+2%	$4.32	13G/A	31 Mar 2025	14 May 2025, 12:13
JANUS HENDERSON GROUP PLC	10%	+72%	$16,364,920	3,788,176	-1,660,511	-30%	$4.32	13G/A	28 Feb 2025	07 Mar 2025, 12:58
Janus Henderson Biotech Innovation Master Fund Ltd	6%		$23,538,328	5,448,687			$4.32	13G	31 Dec 2024	14 Feb 2025, 11:23

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$27,379,105	5,141,616	+910,285	+22%	$5.32	Q4 2025
30 Sep 2025	0.01%	+0%	$18,363,977	4,231,331	+128,711	+3.1%	$4.34	Q3 2025
30 Jun 2025	0.01%	+0%	$12,451,452	4,102,620	+314,444	+8.3%	$3.04	Q2 2025
31 Mar 2025	0.01%	+0%	$17,387,728	3,788,176	+1,516,344		$4.59	Q1 2025
31 Dec 2024	0.01%	+0.01%	$11,938,477	2,271,832	+2,271,832	NEW	$5.25	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.